- Previous Close
25.50 - Open
25.33 - Bid --
- Ask --
- Day's Range
24.68 - 25.50 - 52 Week Range
24.68 - 63.58 - Volume
881,589 - Avg. Volume
713,718 - Market Cap (intraday)
1.154B - Beta (5Y Monthly) 1.66
- PE Ratio (TTM)
-- - EPS (TTM)
-3.17 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 2, 2021
- 1y Target Est
51.60
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
www.azenta.com3,000
Full Time Employees
September 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: AZTA
View MorePerformance Overview: AZTA
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AZTA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AZTA
View MoreValuation Measures
Market Cap
1.15B
Enterprise Value
744.71M
Trailing P/E
--
Forward P/E
51.55
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.92
Price/Book (mrq)
0.67
Enterprise Value/Revenue
1.12
Enterprise Value/EBITDA
40.00
Financial Highlights
Profitability and Income Statement
Profit Margin
-24.44%
Return on Assets (ttm)
-1.65%
Return on Equity (ttm)
-7.99%
Revenue (ttm)
662.11M
Net Income Avi to Common (ttm)
-166.4M
Diluted EPS (ttm)
-3.17
Balance Sheet and Cash Flow
Total Cash (mrq)
463.44M
Total Debt/Equity (mrq)
3.16%
Levered Free Cash Flow (ttm)
11.1M